Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy?

Area of Science:

• Neuroscience
• Infectious Diseases
• Biochemistry

Background:

• Pneumococcal meningitis remains a significant cause of morbidity and mortality despite treatment.
• Reactive oxygen species (ROS) and reactive nitrogen species (RNS), including peroxynitrite, are excessively produced during pneumococcal meningitis.
• These species cause collateral damage through lipid peroxidation, DNA damage, inflammation, and matrix metalloproteinase activation.

Purpose of the Study:

• To investigate the role of ROS and RNS in the pathogenesis of pneumococcal meningitis.
• To evaluate N-acetyl-l-cysteine (NAC) as a potential adjunctive therapy targeting ROS and RNS.

Main Methods:

• Utilized animal models of experimental pneumococcal meningitis.
• Assessed the effects of ROS and RNS production on meningeal inflammation, blood-brain barrier integrity, cerebral autoregulation, neuronal survival, and cochlear damage.
• Administered NAC to evaluate its therapeutic efficacy.

Main Results:

• ROS and RNS production contribute to severe meningeal inflammation, blood-brain barrier disruption, altered cerebral autoregulation, neuronal death, and cochlear destruction in animal models.
• NAC treatment significantly ameliorated cerebral and cochlear complications in these models.

Conclusions:

• The excessive production of ROS and RNS plays a crucial role in the poor outcomes associated with pneumococcal meningitis.
• NAC represents a promising adjunctive therapeutic strategy for mitigating the severe neurological and auditory complications of pneumococcal meningitis.